Kei Asayama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kei Asayama has a total of 557 co-authors. Here are the top co-authors by number of shared publications:
- Takayoshi Ohkubo
Department of Hygiene and Public Health Teikyo University School of Medicine Tokyo Japan
33 shared publications Yutaka Imai
Tohoku Institute for Management of Blood Pressure , Hanamaki, Iwate 028-3203
20 shared publications- Jan A. Staessen
Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
18 shared publications - Masahiro Kikuya
Teikyo University
17 shared publications - Hirohito Metoki
Tohoku Medical and Pharmaceutical University
15 shared publications Takayoshi Ohkubo
Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan
15 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (20)
Nonlinear 24‐Hour Blood Pressure Dynamics in Cognitive Impairment and Dementia
Background: In cognitive impairment and dementia, where biological functions are disrupted, nonlinear dynamics may reflect dysregulation of blood pressure (BP) that might not be captured by linear variability. We investigated whether nonlinear dynamics of 24‐hour BP variability are associated with cognitive impairment and dementia. Methods: We conducted a cross‐sectional analysis of 4854 participants from 3 population‐based studies. Raw 24‐hour ambulatory BP recordings were structured as time series to quantify nonlinear variability using sample entropy, detrended fluctuation analysis, and Poincaré measures. High entropy and Poincaré values with low detrended fluctuation analysis suggest irregular dynamics, whereas the opposite pattern indicates a predictable BP system. Neurological outcomes included Mini‐Mental State Examination, mild cognitive impairment (n=212), and dementia (n=111). Results: The mean age was 67.6±7.89 years (61.0% women). Higher 24‐hour systolic BP entropy and Poincaré measures were associated with lower Mini‐Mental State Examination; adjusted‐mean Mini‐Mental State Examination estimates ranged from −0.119 (95% CI, −0.184 to −0.053) to −0.035 (95% CI, −0.060 to −0.010). These measures were also associated with higher odds for prevalent mild cognitive impairment (odds ratios [OR] ≥1.41) and dementia (ORs ranged from 1.32 [95% CI, 1.08–1.60] to 2.36 [95% CI, 1.49–3.74]). Lower detrended fluctuation analysis was related to dementia (OR, 1.64 [95% CI, 1.01–2.68]). Sex, antihypertensive medication, and measures of linear variability did not modify the association between nonlinear variability and cognitive outcomes. Conclusions: Nonlinear 24‐hour BP dynamics were associated with cognitive impairment and dementia. Nonlinear patterns of irregular 24‐hour variability may represent a form of BP dysregulation relevant to dementia.
- 20 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (20)
Open AccessNonlinear 24‐Hour Blood Pressure Dynamics in Cognitive Impairment and Dementia
Background: In cognitive impairment and dementia, where biological functions are disrupted, nonlinear dynamics may reflect dysregulation of blood pressure (BP) that might not be captured by linear variability. We investigated whether nonlinear dynamics of 24‐hour BP variability are associated with cognitive impairment and dementia. Methods: We conducted a cross‐sectional analysis of 4854 participants from 3 population‐based studies. Raw 24‐hour ambulatory BP recordings were structured as time series to quantify nonlinear variability using sample entropy, detrended fluctuation analysis, and Poincaré measures. High entropy and Poincaré values with low detrended fluctuation analysis suggest irregular dynamics, whereas the opposite pattern indicates a predictable BP system. Neurological outcomes included Mini‐Mental State Examination, mild cognitive impairment (n=212), and dementia (n=111). Results: The mean age was 67.6±7.89 years (61.0% women). Higher 24‐hour systolic BP entropy and Poincaré measures were associated with lower Mini‐Mental State Examination; adjusted‐mean Mini‐Mental State Examination estimates ranged from −0.119 (95% CI, −0.184 to −0.053) to −0.035 (95% CI, −0.060 to −0.010). These measures were also associated with higher odds for prevalent mild cognitive impairment (odds ratios [OR] ≥1.41) and dementia (ORs ranged from 1.32 [95% CI, 1.08–1.60] to 2.36 [95% CI, 1.49–3.74]). Lower detrended fluctuation analysis was related to dementia (OR, 1.64 [95% CI, 1.01–2.68]). Sex, antihypertensive medication, and measures of linear variability did not modify the association between nonlinear variability and cognitive outcomes. Conclusions: Nonlinear 24‐hour BP dynamics were associated with cognitive impairment and dementia. Nonlinear patterns of irregular 24‐hour variability may represent a form of BP dysregulation relevant to dementia.
- Open Access
- 2 October 2026
- Published by Springer Nature in Hypertension Research
- p. 1-9
Association of hypertension specialist treatment with blood pressure control in Japanese primary care: The J-DOME study
Although hypertension is a major contributor to cardiovascular complications, real-world blood pressure (BP) control in primary care and the role of hypertension specialists remain incompletely characterized. We evaluated BP control and associated factors using the Japan Medical Association Database of Clinical Medicine (J-DOME), a nationwide primary care registry. This cross-sectional study included patients with hypertension registered in 2024, categorized by treatment by specialists certified by the Japanese Society of Hypertension. Multivariable logistic regression identified factors associated with achieving office BP < 130/80 mmHg. Among 2663 patients (43.6% women; mean age, 71.4 years), 545 were treated by hypertension specialists. Mean BP was 134.4/74.8 mmHg, and the mean number of antihypertensive drugs was 1.6. Systolic BP was similar between specialist- and non-specialist-treated patients (135.1 vs . 134.2 mmHg; p = 0.28), whereas diastolic BP (76.1 vs . 74.5 mmHg; p = 0.0060) and the number of drugs (1.9 vs . 1.6; p < 0.0001) were higher in the specialist-treated group. Target BP achievement rate was lower in the specialist-treated group (30.8% vs . 37.3%; p = 0.0058), however, this difference was not observed among patients aged p = 0.55). The multivariable-adjusted model revealed that diabetes mellitus (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.08–1.61) and a higher number of drugs (OR per additional drug, 1.12; 95% CI, 1.04–1.22) were associated with higher target achievement, whereas overweight (OR, 0.70; 95% CI, 0.58–0.85), obesity (OR, 0.57; 95% CI, 0.42–0.77), and specialist treatment (OR, 0.77; 95% CI, 0.61–0.96) were associated with lower achievement. Office BP control remains suboptimal in Japanese primary care. Lower achievement among specialist-treated patients despite more drugs may reflect the concentration of difficult-to-control hypertension in specialist care. Continued efforts to improve hypertension management, particularly in patients with obesity, are warranted.
- 2 October 2026
- Published by Springer Nature in Hypertension Research
- p. 1-9
Open AccessAssociation of hypertension specialist treatment with blood pressure control in Japanese primary care: The J-DOME study
Although hypertension is a major contributor to cardiovascular complications, real-world blood pressure (BP) control in primary care and the role of hypertension specialists remain incompletely characterized. We evaluated BP control and associated factors using the Japan Medical Association Database of Clinical Medicine (J-DOME), a nationwide primary care registry. This cross-sectional study included patients with hypertension registered in 2024, categorized by treatment by specialists certified by the Japanese Society of Hypertension. Multivariable logistic regression identified factors associated with achieving office BP < 130/80 mmHg. Among 2663 patients (43.6% women; mean age, 71.4 years), 545 were treated by hypertension specialists. Mean BP was 134.4/74.8 mmHg, and the mean number of antihypertensive drugs was 1.6. Systolic BP was similar between specialist- and non-specialist-treated patients (135.1 vs . 134.2 mmHg; p = 0.28), whereas diastolic BP (76.1 vs . 74.5 mmHg; p = 0.0060) and the number of drugs (1.9 vs . 1.6; p < 0.0001) were higher in the specialist-treated group. Target BP achievement rate was lower in the specialist-treated group (30.8% vs . 37.3%; p = 0.0058), however, this difference was not observed among patients aged p = 0.55). The multivariable-adjusted model revealed that diabetes mellitus (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.08–1.61) and a higher number of drugs (OR per additional drug, 1.12; 95% CI, 1.04–1.22) were associated with higher target achievement, whereas overweight (OR, 0.70; 95% CI, 0.58–0.85), obesity (OR, 0.57; 95% CI, 0.42–0.77), and specialist treatment (OR, 0.77; 95% CI, 0.61–0.96) were associated with lower achievement. Office BP control remains suboptimal in Japanese primary care. Lower achievement among specialist-treated patients despite more drugs may reflect the concentration of difficult-to-control hypertension in specialist care. Continued efforts to improve hypertension management, particularly in patients with obesity, are warranted.
- 4 May 2026
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 84 (9) , 997-1006
Current perspective on seasonal variation in blood pressure
Blood pressure (BP) fluctuates with an annual cycle, with BP levels generally lower in summer and higher in winter. In this narrative review with a quasi-systematic literature search, we aim to summarise current evidence from a wide variety of research fields on seasonal BP variability, and to present our findings to stimulate interest in this largely unexplored area. Environmental temperature would be the key driver of seasonal BP variation, while other external and internal factors mediate this variation; quantifying these effects is difficult because of the various factors and their interactions. Self-measured home BP would be the most favorable information for evaluating long-term seasonal BP changes. Nocturnal home BP reduction is lower in summer than in winter, leading to a higher prevalence of a riser BP pattern in summer; we need to pay attention to the various risk factors associated with higher BP across seasons. Temperature obviously affects BP; therefore, it seems reasonable to assume that seasonal BP changes linearly contribute to seasonal mortality variation. However, our patients database showed that there are >10% of patients whose home BP is higher in summer than in winter, and the cardiovascular risk was significantly higher in patients with such inverse seasonal variation as well as those with contrarily large-sized seasonal variation in home BP (≥9.1 mm Hg in systolic or ≥4.5 mm Hg in diastolic measurements) than in those with the other small- to middle-sized seasonal variation. The inverse seasonal BP pattern is not rare in patients under antihypertensive drug treatment, and the mechanisms warrant investigation. Although the importance of BP level as a dominant and modifiable risk factor should be emphasized, assessing seasonal BP variation through long-term BP measurement, particularly based on home BP monitoring, has clinical benefits and should be widely promoted.
- 4 May 2026
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 84 (9) , 997-1006
Current perspective on seasonal variation in blood pressure
Blood pressure (BP) fluctuates with an annual cycle, with BP levels generally lower in summer and higher in winter. In this narrative review with a quasi-systematic literature search, we aim to summarise current evidence from a wide variety of research fields on seasonal BP variability, and to present our findings to stimulate interest in this largely unexplored area. Environmental temperature would be the key driver of seasonal BP variation, while other external and internal factors mediate this variation; quantifying these effects is difficult because of the various factors and their interactions. Self-measured home BP would be the most favorable information for evaluating long-term seasonal BP changes. Nocturnal home BP reduction is lower in summer than in winter, leading to a higher prevalence of a riser BP pattern in summer; we need to pay attention to the various risk factors associated with higher BP across seasons. Temperature obviously affects BP; therefore, it seems reasonable to assume that seasonal BP changes linearly contribute to seasonal mortality variation. However, our patients database showed that there are >10% of patients whose home BP is higher in summer than in winter, and the cardiovascular risk was significantly higher in patients with such inverse seasonal variation as well as those with contrarily large-sized seasonal variation in home BP (≥9.1 mm Hg in systolic or ≥4.5 mm Hg in diastolic measurements) than in those with the other small- to middle-sized seasonal variation. The inverse seasonal BP pattern is not rare in patients under antihypertensive drug treatment, and the mechanisms warrant investigation. Although the importance of BP level as a dominant and modifiable risk factor should be emphasized, assessing seasonal BP variation through long-term BP measurement, particularly based on home BP monitoring, has clinical benefits and should be widely promoted.
- Open Access
- 1 March 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (3) , e25442
End Point–Based Threshold for the Ambulatory Arterial Stiffness Index
BACKGROUND: The ambulatory arterial stiffness index (AASI) is increasingly used in clinical research and practice. This individual-participant meta-analysis aims to consolidate the prognostic accuracy of AASI in the general population and to derive an end point–based AASI risk threshold. METHODS: In 12 558 individuals enrolled in 14 population studies (48.8% women; mean age, 59.3 years), AASI was derived by regressing 24-hour diastolic on systolic blood pressure (mm Hg/mm Hg). Using Cox regression, the risk-carrying AASI threshold was established by examining stepwise increasing AASI levels and by determining the AASI level, yielding a 10-year risk similar to an office systolic pressure of 140 mm Hg. RESULTS: Over 10.7 years (median), 3027 all-cause deaths and 2183 cardiovascular end points occurred. In all participants, multivariable-adjusted hazard ratios expressing the all-cause deaths and cardiovascular end point risk per 1-SD AASI increment were 1.08 (95% CI, 1.04–1.13) and 1.13 (95% CI, 1.07–1.18). In a randomly defined subset of 8189 individuals, the risk-carrying AASI thresholds converged to 0.50 with hazard ratios (≥0.50 versus <0.50) of 1.14 (95% CI, 1.04–1.26) for all-cause deaths and 1.13 (95% CI, 1.01–1.26) for cardiovascular end point. In the replication sample (n=4369), these hazard ratios were 1.13 (95% CI, 1.01–1.26) and 1.19 (95% CI, 1.04–1.35). AASI continuous or per threshold significantly improved model performance. Analyses of secondary end points and subgroups stratified by sex, age, hypertension status and treatment, history of cardiovascular disease, and nocturnal dipping were confirmatory. CONCLUSIONS: Over and beyond traditional risk factors, AASI improves risk stratification. Exceeding the risk-carrying 0.50 AASI threshold necessitates increased vigilance in managing risk factors before irreversible cardiovascular complications occur.
- 1 March 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (3) , e25442
Open AccessEnd Point–Based Threshold for the Ambulatory Arterial Stiffness Index
BACKGROUND: The ambulatory arterial stiffness index (AASI) is increasingly used in clinical research and practice. This individual-participant meta-analysis aims to consolidate the prognostic accuracy of AASI in the general population and to derive an end point–based AASI risk threshold. METHODS: In 12 558 individuals enrolled in 14 population studies (48.8% women; mean age, 59.3 years), AASI was derived by regressing 24-hour diastolic on systolic blood pressure (mm Hg/mm Hg). Using Cox regression, the risk-carrying AASI threshold was established by examining stepwise increasing AASI levels and by determining the AASI level, yielding a 10-year risk similar to an office systolic pressure of 140 mm Hg. RESULTS: Over 10.7 years (median), 3027 all-cause deaths and 2183 cardiovascular end points occurred. In all participants, multivariable-adjusted hazard ratios expressing the all-cause deaths and cardiovascular end point risk per 1-SD AASI increment were 1.08 (95% CI, 1.04–1.13) and 1.13 (95% CI, 1.07–1.18). In a randomly defined subset of 8189 individuals, the risk-carrying AASI thresholds converged to 0.50 with hazard ratios (≥0.50 versus <0.50) of 1.14 (95% CI, 1.04–1.26) for all-cause deaths and 1.13 (95% CI, 1.01–1.26) for cardiovascular end point. In the replication sample (n=4369), these hazard ratios were 1.13 (95% CI, 1.01–1.26) and 1.19 (95% CI, 1.04–1.35). AASI continuous or per threshold significantly improved model performance. Analyses of secondary end points and subgroups stratified by sex, age, hypertension status and treatment, history of cardiovascular disease, and nocturnal dipping were confirmatory. CONCLUSIONS: Over and beyond traditional risk factors, AASI improves risk stratification. Exceeding the risk-carrying 0.50 AASI threshold necessitates increased vigilance in managing risk factors before irreversible cardiovascular complications occur.
- Open Access
- 9 January 2026
- Published by Springer Nature in Hypertension Research
- Vol. 49 (3) , 993-996
Definition and classification of office and out-of-office blood pressure across recent guidelines
- 9 January 2026
- Published by Springer Nature in Hypertension Research
- Vol. 49 (3) , 993-996
Open AccessDefinition and classification of office and out-of-office blood pressure across recent guidelines
- 8 September 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 142, 106501
Treatment target of blood pressure: Changes in evidence-based guidelines and impact of measurement conditions
- 8 September 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 142, 106501
Treatment target of blood pressure: Changes in evidence-based guidelines and impact of measurement conditions
- 15 August 2025
- Published by Springer Nature in Hypertension Research
- Vol. 48 (10) , 2515-2520
Kiosk blood pressure measurement in Japan: clinical and population application
Kiosk blood pressure measurement refers to the self-measurement of blood pressure unattended by medical staff using an automated device in workplaces or public spaces, e.g., gymnasiums, shopping malls, or governmental facilities. Kiosk blood pressure devices consist mainly of automated rolling-type sphygmomanometers that are widely used in health check-ups, hospital waiting rooms, pharmacies, and even at home. The distinguished advantage of kiosk blood pressure measurement is that there can be a casual opportunity to self-measure blood pressure, making them suitable for the identification of high blood pressure. We propose to apply the term "kiosk blood pressure measurement" to all kinds of blood pressure self-measurement out-of-home, and to perform kiosk blood pressure measurements as closely as possible, similar to the self-measured home blood pressure condition, since it is a self-measurement and an unattended setting. Although kiosk blood pressure has various challenges, such as device validation, measurement environments, conditions, and long-term maintenance, we should recognize its benefits and encourage people to know their own blood pressure through the kiosk measurement, leading to self-care for their high blood pressure.
- 15 August 2025
- Published by Springer Nature in Hypertension Research
- Vol. 48 (10) , 2515-2520
Kiosk blood pressure measurement in Japan: clinical and population application
Kiosk blood pressure measurement refers to the self-measurement of blood pressure unattended by medical staff using an automated device in workplaces or public spaces, e.g., gymnasiums, shopping malls, or governmental facilities. Kiosk blood pressure devices consist mainly of automated rolling-type sphygmomanometers that are widely used in health check-ups, hospital waiting rooms, pharmacies, and even at home. The distinguished advantage of kiosk blood pressure measurement is that there can be a casual opportunity to self-measure blood pressure, making them suitable for the identification of high blood pressure. We propose to apply the term "kiosk blood pressure measurement" to all kinds of blood pressure self-measurement out-of-home, and to perform kiosk blood pressure measurements as closely as possible, similar to the self-measured home blood pressure condition, since it is a self-measurement and an unattended setting. Although kiosk blood pressure has various challenges, such as device validation, measurement environments, conditions, and long-term maintenance, we should recognize its benefits and encourage people to know their own blood pressure through the kiosk measurement, leading to self-care for their high blood pressure.
- Open Access
- 2 June 2025
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 4 (6) , pgaf179
One-hour postload glucose levels predict mortality from cardiovascular diseases and malignant neoplasms in healthy subjects
Little is known about biological markers, at levels within their normal ranges which might predict future mortality. We aimed at identifying possible predictors of future death in participants before pathological conditions manifest. We analyzed data from a population-based prospective cohort study (the Ohasama study), comprised of 993 participants who underwent 75-g oral glucose tolerance tests (OGTTs). We collected blood parameters, including those measured during OGTTs, and divided the study population into two groups based on the median value of each parameter, followed by analyses of mortality during follow-up in both groups. In addition, we extracted subjects with normal glucose tolerance (NGT) (n = 595) and analyzed the association between 1-h postload plasma glucose during OGTTs (1-hrPG) and mortality as well as the causes of death. Among all parameters evaluated, 1-hrPG was found to be most significantly associated with all-cause mortality during the mean follow-up of 14.3 years. When we focused on subjects with NGT, Harrell's C concordance index analysis revealed a cut-off of 1-hrPG ≥170 mg/dL to be most strongly associated with all-cause mortality (0.8066). The Kaplan–Meier plots showed nearly double the proportion of the 1-hrPG ≥170 group to have died as compared with the 1-hrPG <170 group throughout the follow-up period after the third year. Cardiovascular diseases and malignant neoplasms both strongly contributed to the increased mortality in the high 1-hrPG group. Thus, 1-hrPG ≥170 is a powerful predictor of future death in subjects with NGT. Atherosclerotic and malignant diseases both contributed to the increased mortality.
- 2 June 2025
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 4 (6) , pgaf179
Open AccessOne-hour postload glucose levels predict mortality from cardiovascular diseases and malignant neoplasms in healthy subjects
Little is known about biological markers, at levels within their normal ranges which might predict future mortality. We aimed at identifying possible predictors of future death in participants before pathological conditions manifest. We analyzed data from a population-based prospective cohort study (the Ohasama study), comprised of 993 participants who underwent 75-g oral glucose tolerance tests (OGTTs). We collected blood parameters, including those measured during OGTTs, and divided the study population into two groups based on the median value of each parameter, followed by analyses of mortality during follow-up in both groups. In addition, we extracted subjects with normal glucose tolerance (NGT) (n = 595) and analyzed the association between 1-h postload plasma glucose during OGTTs (1-hrPG) and mortality as well as the causes of death. Among all parameters evaluated, 1-hrPG was found to be most significantly associated with all-cause mortality during the mean follow-up of 14.3 years. When we focused on subjects with NGT, Harrell's C concordance index analysis revealed a cut-off of 1-hrPG ≥170 mg/dL to be most strongly associated with all-cause mortality (0.8066). The Kaplan–Meier plots showed nearly double the proportion of the 1-hrPG ≥170 group to have died as compared with the 1-hrPG <170 group throughout the follow-up period after the third year. Cardiovascular diseases and malignant neoplasms both strongly contributed to the increased mortality in the high 1-hrPG group. Thus, 1-hrPG ≥170 is a powerful predictor of future death in subjects with NGT. Atherosclerotic and malignant diseases both contributed to the increased mortality.
- 1 June 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (6) , 945-956
Asian Expert Consensus on Nocturnal Hypertension Management
There is consistent and strong evidence that nighttime blood pressure is a better predictor of target organ damage and cardiovascular events, and the prevalence of nocturnal hypertension is high in all populations but higher in Asians than Europeans. Excessive salt intake and salt sensitivity have long been believed to be risk factors for elevated nighttime blood pressure in Asians. For various reasons, the control rate of nocturnal hypertension is low, for example, insufficient monitoring and inappropriate therapeutic regimens. With the increasing evidence and possibility of management, it is highly relevant to have thorough discussions among Asian experts and to reach a consensus on major aspects in regard to the management of nocturnal hypertension. The consensus involves 5 aspects, including definitions and diagnosis, epidemiology, risk and risk factors, treatment, and future perspectives.
- 1 June 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (6) , 945-956
Asian Expert Consensus on Nocturnal Hypertension Management
There is consistent and strong evidence that nighttime blood pressure is a better predictor of target organ damage and cardiovascular events, and the prevalence of nocturnal hypertension is high in all populations but higher in Asians than Europeans. Excessive salt intake and salt sensitivity have long been believed to be risk factors for elevated nighttime blood pressure in Asians. For various reasons, the control rate of nocturnal hypertension is low, for example, insufficient monitoring and inappropriate therapeutic regimens. With the increasing evidence and possibility of management, it is highly relevant to have thorough discussions among Asian experts and to reach a consensus on major aspects in regard to the management of nocturnal hypertension. The consensus involves 5 aspects, including definitions and diagnosis, epidemiology, risk and risk factors, treatment, and future perspectives.